INTRODUCTION
The c-myc gene product is a nuclear protein with a short half-life which has been implicated in growth regulation (for reviews see Rabbits, 1985; Cole, 1986; Eisenman & Thompson, 1986) . When quies¬ cent cells, which express low levels of both c-myc mRNA and protein, are stimulated to initiate proliferation, rapid accumulation of c-myc mRNA occurs within 2 h (Kelly, Cochran, Stiles & Leder, 1983; Makino, Hayashi & Sugimura, 1984;  Thomp¬ son, Challoner, Neiman & Grondine, 1985) . The gene product probably acts as a competence factor, allowing cells to progress through the cell cycle (Campisi, Gray, Pardee et al. 1984; Hann, Thomp¬ son & Eisenman, 1985; Thompson et al. 1985; Sudzinski, Brelvi, Feldman & Watt, 1986) . Further¬ more, terminal differentiation is preceded by a decrease in the level of c-myc (Lachman & Skoultchi, 1984; Hann et al. 1985) , and differentia¬ tion can be blocked by increased c-myc expression (Kaneko-Ishino, Kume, Sasaki et al. 1988 ) as well as be induced by the expression of antisense myc transcripts (Griep & Westphal, 1988; Holt, Redner & Nienhuis, 1988) . The protein is under strict regulatory control at both the transcriptional and the post-transcriptional level (Krystal, Birrer, Way et al. 1988; Lindsten, June & Swartwont & Kinniburgh, 1989) . Overexpression or misregulation of the c-myc gene has been shown to be at least partially responsible for cell transfor¬ mation (Klein, 1983; Land, Parada & Weinberg, 1983; Keath, Kelekar & Cole, 1984; Potter & Mushinski, 1984; Stewart, Pattengale & Leder, 1984; Adams, Harris, Pinkert et al. 1985; Krystal et al. 1988) .
Growth hormone (GH), released from the pitui¬ tary, is a major hormone in the regulation of somatic growth and intermediary metabolism (Li, Evans & Simpson, 1945; Kostyo & Nutting, 1973;  Altszuler, 1974; Goodman & Schwarz, 1974) . In addition, GH is involved in the regulation of sex-differentiated metabolism of steroids and xenobiotics in rat liver (Mode, Norstedt, Simic et al. 1981; Mode, Gustafs-son, Jansson et al. 1982; Blanck, Äström, Hansson et al. 1986è ). This sexually differentiating influence of GH is exerted by the secretory pattern of the hormone, which becomes different in the sexes from the onset of puberty (Edén, 1979; Mode et al. 1982) . In male rats the basal serum level of GH is very low, with regular peaks every 3-4 h, while in females the basal level is higher, with lower more irregular peaks (Edén, 1979) . The secretion of GH seems to be regulated at the hypothalamic level by the combined action of somatostatin, which has been shown to inhibit GH release in male rats, and a GH-releasing factor (Shaffer Tannenbaum & Ling, 1984) . The male secretory pattern is imprinted neonatally at the hypothalamic level by testicular androgens (Mode, Eneroth, Gustafsson et al. 1980) and is maintained by the constant influence of testosterone. The high basal level of GH in the female rat seems to be a prerequisite for the female pattern of hepatic steroid-metabolizing enzymes. Several endocrine manipulations can be performed to raise the basal level of GH in the male rat, leading to 'feminization' of several sex-differentiated hepatic functions, in¬ cluding sex-specific forms of cytochrome P-450 (Mode et al. 1981 (Mode et al. , 1982 . These manipulations include implantation of ectopic pituitary grafts (Eneroth, Gustafsson, Skett & Stenberg, 1977) , continuous infusion of GH (Blanck et al. 19866 ), neonatal and adult castration (Jansson, Ekberg, Isaksson et al. 1985; Blanck, Äström & Hansson, 1986a) , oestrogen administration (Rumbaugh & Colby, 1980) and hypothalamic deafferentation at the suprachiasmatic level (Mode et al. 1980 ). In conclusion, an important part of the effects of gonadal hormones on rat liver metabolism is medi¬ ated through the hypothalamo-pituitary-liver axis.
Our previous studies have demonstrated that the sexual dimorphism observed in rat liver carcinogenesis using the 'resistant hepatocyte model' (Färber, 1980) is also regulated through the secretory pattern of GH (Blanck, Hansson, Eriksson & Gustafsson, 1984 Blanck, Hansson, Gustafsson & Eriksson, 1986c (Durham & Palmiter, 1983) . The content of total nucleic acids of the TNA samples was determined photometrically and the DNA content quantified using a fluorimetric assay (Labarca & Pargen, 1980 at 35 days. The castrated and GH-treated male rats had activities similar to the females, while testoster¬ one-supplemented castrated rats had decreased 5oc/16oc ratios (Table 2) , indicating the efficiency of the endocrine manipulations.
Ontogenetic development of c-myc expression The age-and sex-dependent expression of the hepatic c-myc gene, measured by solution hybridization, is shown in Fig. 1 (Fig. 2) . Castration, either neonatal (within 36 h of birth) or of adults (42 days) also led to decreased c-myc expression (Fig. 3 (Table 3) . No sex differences could be discerned, and expression was not altered in GH-treated or castrated rats (Table 4) .
DISCUSSION
In the present study we have demonstrated that sexual dimorphism in the expression of the c-myc gene in rat liver is established at the time of puberty (Fig. 1) . The sex difference in adult animals could be (Lachman & Skoultchi, 1984; Griep & Westphal, 1988; Holt et al. 1988 ; Kaneko-Ishino et al. 1988 ).
The more pronounced feminizing effect of neo¬ natal than of adult castration on hepatic steroid metabolism observed in the present study is in accordance with previous findings (Blanck et al. 1986a, b, c) . Also, neonatal castration was slightly more efficient than adult castration with respect to down-regulation of c-myc expression. Interestingly, sham castration of neonatal rats significantly de¬ creased c-myc expression compared with that in intact male rats and male rats sham operated when adult. The significant effect of neonatal sham castration on the metabolism of 4-androstene-3,17-dione is also consistent with previous findings (Blanck et al. 1986a, b, c) . The effect of neonatal sham operation on the imprinting of c-myc expres¬ sion indicates that non-specific disturbances, such as physical trauma, in the perinatal period might affect growth regulation in later life.
The observation of a GH-regulated sexual dimor¬ phism in c-myc expression in the liver leads to the question of whether this gene is regulated by GH in other target tissues for GH, e.g. muscle cells.
In conclusion, the present paper shows the involvement of the hypothalamo-pituitary-liver axis in the regulation of the expression of a proto-oncogene involved in regulation of proliferation. This observation might lead to further insight into the complex mechanisms of action of GH.
